CeGaT, a global provider of genetic testing and sequencing services, announces the expansion of its world-class genetic testing services across the United States and Canada. Partnerships with numerous commercial insurers further support this strategic expansion, ensuring broad accessibility and insurance coverage for more patients. Just recently, CeGaT has been awarded the national contract with Blue […]
continue reading
CeGaT, a global provider of genetic diagnostics and sequencing services based in Tübingen, Germany, is celebrating several events: CeGaT turns 15 years old today. The inauguration of the extension triples the size of the CeGaT building. And furthermore, the family-run company is again fully owned by the founders since April 1, 2024. Since its foundation […]
continue reading
CeGaT, ein weltweiter Anbieter von genetischer Diagnostik und Sequenzierdienstleistungen mit Sitz in Tübingen, feiert drei Ereignisse: Am heutigen Tag wird CeGaT 15 Jahre alt. Mit der Einweihung des Erweiterungsbaus verdreifacht sich die Fläche des CeGaT-Gebäudes. Und zudem befindet sich das familiengeführte Unternehmen seit dem 01. April 2024 wieder vollständig im Eigentum der Gründer. Seit der […]
continue reading
CeGaT, a global provider of genetic diagnostics and sequencing services, presents an innovation in exome diagnostics: With the integration of a CNV backbone, it is now possible for the first time to analyze copy number changes in the entire genome within the scope of exome sequencing. As a result, the solution rate of patient cases […]
continue reading
CeGaT, a global provider of sequencing services for research, clinical studies, and human genetic diagnostics, is now using the latest and most powerful sequencing system from Illumina. With the NovaSeq™ X Plus, CeGaT can carry out research projects previously considered unfeasible due to their enormous data volume. Since mid-March, CeGaT has been one of the […]
continue reading
CeGaT, ein global agierender Anbieter von Sequenzierdienstleistungen für Forschung, klinische Studien und humangenetische Diagnostik, setzt ab sofort das neuste und leistungsstärkste Sequenziersystem von Illumina ein. Mit dem NovaSeq™ X Plus kann CeGaT Forschungsprojekte umsetzen, die aufgrund ihres enormen Datenvolumens bislang als unrealisierbar galten. Seit Mitte März verfügt CeGaT als eines der ersten Unternehmen weltweit über […]
continue reading
CeGaT, a global provider of sequencing services for research, clinical trials, and human genetic diagnostics, is the first provider in Germany that has equipped its sequencing laboratory with the PacBio system. The Single Molecule Real-Time (SMRT) technology behind it allows the generation of HiFi reads with exceptional accuracy and length. Using this technology, CeGaT now […]
continue readingCeGaT, a global provider of sequencing services for research, clinical trials and human genetic diagnostics, is expanding its NGS laboratory with the brand new NovaSeq™ X from Illumina. This strategically important step enables CeGaT to serve the growing global demand for sequencing services and molecular genetic analysis and to make Illumina’s latest sequencing platform available […]
continue reading
CeGaT, ein weltweit agierender Anbieter von genetischen Analysen, feierte am Donnerstag, den 22.09.2022, das Richtfest für den Erweiterungsbau im Technologiepark Tübingen. Neben den Bauarbeitern und dem CeGaT-Team waren auch Christian Erbe, Prof. Bernd Pichler und Boris Palmer als Gäste geladen. Die CeGaT-Geschäftsführer und -Gründer Dr. Dr. Saskia Biskup und Dr. Dirk Biskup bedankten sich im […]
continue reading
CeGaT, a global provider of sequencing services for research, clinical studies, and human genetic diagnostics, is investing in new NovaSeq 6000 sequencing systems from Illumina. This acquisition is a strategically important move given CeGaT’s rapid corporate growth. CeGaT has acquired a sixth and seventh NovaSeq 6000 to meet the increasing demand for sequencing and genetic […]
continue reading